Title Page / Table of Contents
Kjel Öberg, Wolf O. Bechstein(Unknown), Bruno Niederle(Medical University of Vienna), Juan Manuel O’Connor(Instituto Alexander Fleming), Bertram Wiedenmann(Charité - Universitätsmedizin Berlin), Paul Komminoth(Triemli Hospital), Guido Rindi(Agostino Gemelli University Polyclinic), Wouter W. de Herder(Erasmus University Rotterdam), Peter E. Goretzki, Réza Kianmanesh(Hôpital Robert-Debré), José Manuel Lopes, Anders Sundin, Dermot O’Toole(Trinity College Dublin), Jean‐Yves Scoazec(Université Paris-Saclay), James C. Yao(The University of Texas MD Anderson Cancer Center), Valerie Lewington, John Ramage(Hampshire Hospitals NHS Foundation Trust), Aurel Perren(University of Bern), Meike Körner, Maria Luisa Brandi(Vita-Salute San Raffaele University), Jens Ricke(LMU Klinikum), Stefan Wildi, Daniel C. Chung(Massachusetts General Hospital), Guillaume Cadiot, David J. Gross(Princeton University), Stanislas Pauwels, Stanislas Pauwels, Kjell Öberg(Uppsala University Hospital), Emmanuel Mitry, Thomas Steinmüller(DRK Kliniken Berlin), Robert T. Jensen(National Institutes of Health), Håkan Ahlman(University of Gothenburg), Dik J. Kwekkeboom(Erasmus MC), M.I. Sevilla Garcia, Rudolf Arnold(Philipps University of Marburg), Gianfranco Delle Fave(CTO Andrea Alesini), Beata Kos‐Kudła, Philippe Ruszniewski(Inserm), Aldo Scarpa(University of Verona)
Cited by 7
Related Papers
Phase 3 Trial of <sup>177</sup> Lu-Dotatate for Midgut Neuroendocrine Tumors
|New England Journal of Medicine|2017|3.2k
Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment
|Cell Host & Microbe|2013|2.7k
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
|Nature Medicine|2004|2k
Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial
|The Lancet|2008|1.9k
Gastroenteropancreatic neuroendocrine tumours
|The Lancet Oncology|2008|1.8k